Zynerba Pharmaceuticals (stock symbol: ZYNE) Logo in transparent PNG and SVG formats

Zynerba Pharmaceuticals Logo large

Zynerba Pharmaceuticals Logo icon format

Zynerba Pharmaceuticals Logo large for dark backgrounds

Zynerba Pharmaceuticals Logo icon format for dark backgrounds

About Zynerba Pharmaceuticals

Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for transdermal delivery. The company was formerly known as AllTranz, Inc. and changed its name to Zynerba Pharmaceuticals, Inc. in August 2014. Zynerba Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Devon, Pennsylvania.

  • Website domain: zynerba.com
  • Employees: 28
  • Marketcap: $35.5 Million USD

Page last updated on:

August 9th, 2022

Categories: